Broadwood opposes Alcon's STAAR Surgical acquisition bid
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
November 4, 2025 11:52 AM ESTReminds STAARs Board That It Does Not Need Alcons Permission to Remain Independent or Run a Proper Strategic Alternatives Process
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on the investor presentation issued by Alcon Inc. (Alcon) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAARs outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy... More



